Authors: Wieringa, G Shalet, SM

Citation: G. Wieringa et Sm. Shalet, Changes in lipoprotein (a) levels measured by six kit methods during growth hormone treatment of growth hormone deficient adults, GROWTH H I, 10(4), 2000, pp. 231-231

Authors: Wieringa, G Toogood, AA Ryder, WDJ Anderson, JM Mackness, M Shalet, SM

Citation: G. Wieringa et al., Changes in lipoprotein(a) levels measured by six kit methods during growthhormone treatment of growth hormone-deficient adults, GROWTH H I, 10(1), 2000, pp. 14-19

Authors: Wieringa, G

Citation: G. Wieringa, Lipoprotein(a): what's in a measure?, ANN CLIN BI, 37, 2000, pp. 571-580

Authors: Leese, GP Wallymahmed, M Wieringa, G VanHeyningen, C MacFarlane, IA

Citation: Gp. Leese et al., Apo E phenotype and changes in serum lipids in adult patients during growth hormone replacement (vol 140, pg 174, 1999), EUR J ENDOC, 140(3), 1999, pp. 270-270

Authors: Leese, GP Wallymahmed, M Wieringa, G VanHeyningen, C MacFarlane, IA

Citation: Gp. Leese et al., Apo E phenotype and changes in serum lipids in adult patients during growth hormone replacement, EUR J ENDOC, 140(2), 1999, pp. 174-179

Authors: Leese, GP Wallymahmed, M VanHeyningen, C Tames, F Wieringa, G MacFarlane, IA

Citation: Gp. Leese et al., HDL-cholesterol reductions associated with adult growth hormone replacement, CLIN ENDOCR, 49(5), 1998, pp. 673-677